Crystal resistant distillate

CBD crystal resistant distillate for high-minor, flowable formulations.

A CBD distillate designed to resist crystallisation while maintaining a diversified minor cannabinoid profile for easier formulation.

Crystal resistant distillate 43-58% CBD with 15%+ minor cannabinoids Low-THC compliant specification target

Product description

CBD CRD for high-minor, flowable CBD formulations.

CBD CRD is a crystal resistant distillate designed for formulations where flowability, viscosity control, and reduced crystallisation risk are important. The target profile is 43-58% CBD with ≥15% minor cannabinoids and a ≤0.3% THC target, creating a CBD-led oil input with more profile breadth than CBD Isolate.

This format is useful where high CBD powder inputs may create crystallisation or handling challenges. Product teams can use CBD CRD in oil-soluble systems such as tinctures, topical products, edible systems, and vape formats where permitted, while validating carrier compatibility, clarity, viscosity, and stability-study outcomes.

Application fit
Vape formats, tinctures, edibles, skincare, and oil-soluble products
Process route
Chromatographic balancing of CBD potency and minor cannabinoid retention
Release focus
Assay, related cannabinoids, THC target, residual solvents, contaminants, storage, retest period, packaging, and batch documentation.

Purchase enquiry

Request CBD CRD availability and technical documents.

Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.